🇺🇸 FDA
Pipeline program

514G3 (2 mg/kg) plus standard IV antibiotic treatment

2014-PT029

Phase 2 mab completed

Quick answer

514G3 (2 mg/kg) plus standard IV antibiotic treatment for Staphylococcus Aureus Bacteremia is a Phase 2 program (mab) at XBiotech with 1 ClinicalTrials.gov record(s).

Program details

Company
XBiotech
Indication
Staphylococcus Aureus Bacteremia
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials